Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 14, 2018 - Issue
Submit an article Journal homepage
69
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel syndrome

Kristina S Chen1 Outcomes Research and Epidemiology, Shire Human Genetic Therapies, Inc., Cambridge, MA, USA, [email protected]Correspondence[email protected]
,
Jipan Xie2 Analysis Group, Inc., Los Angeles, CA, USA
,
Wenxi Tang3 Analysis Group, Inc., New York, NY, USA
,
Jing Zhao4 Analysis Group, Inc., Boston, MA, USA
,
Palle B Jeppesen5 Department of Medical Gastroenterology, Rigshospitalet, Copenhagen, Denmark
&
James E Signorovitch4 Analysis Group, Inc., Boston, MA, USA
Pages 1267-1277 | Published online: 25 Jul 2018

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Noemi Zorzetti, Vito D’Andrea & Augusto Lauro. (2021) Proteomic biomarkers in short bowel syndrome : are we ready to use them in clinical activity?. Expert Review of Proteomics 18:4, pages 285-293.
Read now

Articles from other publishers (9)

Brune de Dreuille & Francisca Joly. (2022) Disease-modifying therapies in short bowel syndrome. Current Opinion in Pharmacology 65, pages 102240.
Crossref
Karen Slye, Mary McKiernan, Anne Griffin & Alexandra Cremona. (2022) A comparison of a home parenteral nutrition service with the current European (ESPEN) guidelines on chronic intestinal failure in adults. Clinical Nutrition ESPEN 50, pages 289-306.
Crossref
Changzhen Zhu & Yuanxin Li. (2022) An updated overview of glucagon-like peptide-2 analog trophic therapy for short bowel syndrome in adults. Journal of International Medical Research 50:3, pages 030006052210861.
Crossref
Adam Loutfy, Michael Kurin, Raj Shah & Perica Davitkov. (2021) Characterization of American teduglutide consumers from 2015 to 2020: A large database study. Journal of Parenteral and Enteral Nutrition 46:3, pages 646-651.
Crossref
Fabio Bioletto, Chiara D’Eusebio, Fabio Dario Merlo, Umberto Aimasso, Marta Ossola, Marianna Pellegrini, Valentina Ponzo, Alessia Chiarotto, Antonella De Francesco, Ezio Ghigo & Simona Bo. (2022) Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis. Nutrients 14:4, pages 796.
Crossref
Francisco J. Vílchez-López, Laura Larrán-Escandón, José M. García Almeida, Carmen Arraiza-Irigoyen, José A. Irles Rocamora, María J. Molina-Puerta, Juan B. Molina Soria, José L. Pereira Cunill, Juana M. Rabat Restrepo, María I. Rebollo-Pérez, María P. Serrano Aguayo, Carmen Tenorio-Jiménez, Gabriel Olveira & Pedro P. García Luna. (2021) Evidence-based recommendations of the Andalusian Group for Nutrition Reflection and Investigation (GARIN) for the management of adult patients with short bowel syndrome. Nutrición Hospitalaria.
Crossref
Loris Pironi. (2019) Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short‐Bowel Syndrome: A Review of Recent Literature. Journal of Parenteral and Enteral Nutrition 44:6, pages 968-978.
Crossref
Douglas L. Seidner, Simon M. Gabe, Hak‐Myung Lee, Clément Olivier & Palle Bekker Jeppesen. (2019) Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials. Journal of Parenteral and Enteral Nutrition 44:4, pages 697-702.
Crossref
Andrew Ukleja. (2019) Weaning from Parenteral Nutrition. Gastroenterology Clinics of North America 48:4, pages 525-550.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.